경구 고형 제제(OSD 제제) 산업의 성장 기회

Personalized Medicine and Drug Delivery Technologies Enhance Future Growth Potential

This analysis provides an overview and advancements in the oral solid dosage formulation industry, including an evaluation of the current industry scenario, competitive landscape, and regulatory landscape. The scope of the analysis is global, focusing on North America (NA), Europe, Asia-Pacific (APAC), the Middle East, and Latin America (LATAM). It identifies the most prevalent and emerging business models supporting industry stakeholders in enhancing their competitiveness and service offerings. Discussions on key industry drivers and restraints, partnerships, investment and consolidation activities, disruptive technologies, recent excipient advancements, and present and future trends shed light on the industry's growth potential. Industry use cases will provide brief insights into game-changing participants working toward developing disruptive technologies and patient-centric drugs. The analysis will also help uncover growth opportunities based on megatrends and business models, clinical needs, use cases, market access strategies, and technology trends.

Research Highlights:

• Impact of strategic imperatives on the industry 
• Growth drivers and restraints 
• Oral solid dosage based on API release profile
• R&D pipeline and product innovations
• Small molecule oral dosage market overview
• Small molecule oral solid dosage formulation by therapy area
• Innovations in extended-release dosage forms
• Industry trends and emerging technologies
• Supply chain resilience strategies – focus areas
• Investment trends – Expansion and capability-building initiatives
• Consolidation trends – mergers & acquisitions
• company benchmarking
• oral drug delivery solutions & services
• Growth opportunities

Table of Contents

Transformation Impacting the Oral Solid Dosage Formulation Growth Environment

• Why is it Increasingly Difficult to Grow?
• The Strategic Imperative 8™
• The Impact of the Top 3 Strategic Imperatives on the Oral Solid Dosage Formulation Industry

Ecosystem

• Scope of Analysis
• Industry Definition and Segmentation
• Definition-OSD Based on API Release Profile

Growth Generator

• Growth Drivers
• Growth Restraints

Growth Environment

• R&D Pipeline and Product Innovations
• Small Molecule Oral Dosage Formulation Industry Overview
• Small Molecule OSD Formulation by Therapy Area
• Small Molecule OSD Formulation Therapy Area by Dosage Form

Tablet and Capsule Industry-Innovations and Emerging Trends

• Innovations in Extended Release Dosage forms
• Industry Trends and Emerging Technologies

Tablet and Capsule Industry-Regional Policies and Regulatory Impact

• Regional Policies and Initiatives

Tablet and Capsule Industry-Manufacturing and CDMO Industry Overview

• OSD Manufacturing-Production Flow
• Vendor Ecosystem
• Small Molecule OSD CDMO Industry Revenue
• OSD CDMO Industry Overview
• Supply Chain Resilience Strategies-Focus Areas

Tablet and Capsule Industry-Investment and Consolidation Trends Impacting Growth Themes

• Investment Trends-Expansion and Capability Building
• Consolidation Trends-Mergers & Acquisitions
• Growth Themes and Business Models

Tablet and Capsule Industry-Company Benchmarking based on Differentiated Technologies and Services

• Company Benchmarking-Oral Drug Delivery Solutions and Services
• Company Benchmarking Analysis
• Companies to Watch

Growth Opportunity Universe

• Growth Opportunity 1: Fixed Dose Combination Products for Chronic Diseases
• Growth Opportunity 2: Medical Cannabidiol
• Growth Opportunity 3: Phase-appropriate Services for Orphan Drugs
• Growth Opportunity 4: Additive Manufacturing for Personalized Medicine

Best Practices Recognition

• Best Practices Recognition

Frost Radar

• Frost Radar

Next Steps

• Benefits and Impacts of Growth Opportunities
• Next Steps
• Take the Next Step
• List of Exhibits
• Legal Disclaimer